Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
RepliCel Life Sciences Inc (REPCF)
OTHER OTC:REPCF
Holding REPCF?
Track your performance easily
REPCF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.03 - $0.08
Previous Close$0.04
Volume2.50K
Average Volume (3M)N/A
Market Cap
$916.99K
Enterprise Value$853.59K
Total Cash (Recent Filing)C$148.95K
Total Debt (Recent Filing)C$60.82K
Price to Earnings (P/E)4.7
Beta1.39
Next Earnings
May 06, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)<0.01
Shares Outstanding65,001,560
10 Day Avg. Volume280
30 Day Avg. VolumeN/A
Standard Deviation0.26
R-Squared0.04
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)2.76
Price to Cash Flow (P/CF)-0.90
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
RepliCel Life Sciences News
PremiumCompany Announcements
RepliCel Sells Assets and Licenses Patents for Shareholder Gain
PremiumCompany Announcements
RepliCel Secures Million Dollar CEO-Backed Loan
PremiumCompany Announcements
RepliCel Proposes Asset Sale to Secure Future Royalties
PremiumCompany Announcements
RepliCel Plans Asset Sale and Delisting StrategyRisk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
REPCF FAQ
What was RepliCel Life Sciences Inc’s price range in the past 12 months?
RepliCel Life Sciences Inc lowest stock price was $0.03 and its highest was $0.08 in the past 12 months.
What is RepliCel Life Sciences Inc’s market cap?
Currently, no data Available
When is RepliCel Life Sciences Inc’s upcoming earnings report date?
RepliCel Life Sciences Inc’s upcoming earnings report date is May 06, 2025 which is in 177 days.
How were RepliCel Life Sciences Inc’s earnings last quarter?
RepliCel Life Sciences Inc released its earnings results on Aug 06, 2024. The company reported -$0.002 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.002.
Is RepliCel Life Sciences Inc overvalued?
According to Wall Street analysts RepliCel Life Sciences Inc’s price is currently Overvalued.
Does RepliCel Life Sciences Inc pay dividends?
RepliCel Life Sciences Inc does not currently pay dividends.
What is RepliCel Life Sciences Inc’s EPS estimate?
RepliCel Life Sciences Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does RepliCel Life Sciences Inc have?
RepliCel Life Sciences Inc has 63,656,124 shares outstanding.
What happened to RepliCel Life Sciences Inc’s price movement after its last earnings report?
RepliCel Life Sciences Inc reported an EPS of -$0.002 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of RepliCel Life Sciences Inc?
Currently, no hedge funds are holding shares in REPCF
---
RepliCel Life Sciences Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-66.33%
Trailing 12-Months
Company Description
RepliCel Life Sciences Inc
RepliCel Life Sciences, Inc. operates as a regenerative medicine company. The company focuses on developing autologous cell therapies that address conditions linked to a deficit of healthy cells required for normal healing and function. Its products includes RCT-01, RCS-01, and RCH-01 cell therapies are designed to treat chronic tendinosis, damaged or aged skin, and pattern baldness. The company was founded on April 24, 1967 and is headquartered in Vancouver, Canada.
---
Brainstorm Cell Therapeutics
―
Innoviva
―
Capricor Therapeutics
―
BioLife Solutions
―
---